Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;122(3):380-386.
doi: 10.1016/j.radonc.2017.01.002. Epub 2017 Jan 19.

Patterns of Failure for Patients With Glioblastoma Following O-(2-[ 18 F]fluoroethyl)-L-tyrosine PET- And MRI-guided Radiotherapy

Affiliations

Patterns of Failure for Patients With Glioblastoma Following O-(2-[ 18 F]fluoroethyl)-L-tyrosine PET- And MRI-guided Radiotherapy

Michael Lundemann et al. Radiother Oncol. .

Abstract

Background and purpose: To evaluate the patterns of failure following clinical introduction of amino-acid O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-PET-guided target definition for radiotherapy (RT) of glioblastoma patients.

Materials and methods: The first 66 consecutive patients with confirmed histology, scanned using FET-PET/CT and MRI were selected for evaluation. Chemo-radiotherapy was delivered to a volume based on both MRI and FET-PET (PETvol). The volume of recurrence (RV) was defined on MRI data collected at the time of progression according to RANO criteria.

Results: Fifty patients were evaluable, with median follow-up of 45months. Central, in-field, marginal and distant recurrences were observed for 82%, 10%, 2%, and 6% of the patients, respectively. We found a volumetric overlap of 26%, 31% and 39% of the RV with the contrast-enhancing MR volume, PETvol and the composite MRPETvol, respectively. MGMT-methylation (p=0.03), larger PETvol (p<0.001), and less extensive surgery (p<0.001), were associated with larger PETvol overlap.

Conclusion: The combined MRPETvol had a stronger association with the recurrence volume than either of the modalities alone. Larger overlap of PETvol and RV was observed for patients with MGMT-methylation, less extensive surgery, and large PETvol on the RT-planning scans.

Keywords: FET-PET; Glioma; MRI; Radiotherapy; Recurrence patterns.

Similar articles

See all similar articles

Cited by 8 articles

See all "Cited by" articles

MeSH terms

Feedback